{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:09:45Z","timestamp":1773900585880,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1016\/j.ypmed.2013.01.005","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T14:46:32Z","timestamp":1358520392000},"page":"S50-S53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S","title":["Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia"],"prefix":"10.1016","volume":"57","author":[{"given":"Mas Ayu","family":"Said","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hatim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.H.","family":"Habil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Zafidah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Y.","family":"Haslina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Badiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Ramli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ananjit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sapini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badli","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awang","family":"Bulgiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noran N.","family":"Hairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2013.01.005_bb0005","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.ijo.0801837","article-title":"Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality","volume":"25","author":"Anderson","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR","author":"APA","year":"2000"},{"key":"10.1016\/j.ypmed.2013.01.005_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0020","series-title":"Medical Illness and Schizophrenia","first-page":"61","article-title":"Obesity and schizophrenia","author":"Cohn","year":"2009"},{"key":"10.1016\/j.ypmed.2013.01.005_bb0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v67n0408","article-title":"Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs","volume":"67","author":"Correll","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ypmed.2013.01.005_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/YIC.0b013e32834a5bf6","article-title":"The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs","volume":"26","author":"Falissard","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0035","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1176\/appi.ajp.163.10.1697","article-title":"Medication-induced weight gain and dyslipidemia in patients with schizophrenia","volume":"163","author":"Fenton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ypmed.2013.01.005_bb0040","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ypmed.2013.01.005_bb0045","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0269881109102788","article-title":"The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness","volume":"24","author":"Holt","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0050","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/1741826710389529","article-title":"Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men","volume":"18","author":"Kondo","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"Mcevoy","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archneurpsyc.1942.02290010048004","article-title":"Biochemical disturbances in mental disorders","volume":"47","author":"Meduna","year":"1942","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.ypmed.2013.01.005_bb0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.diabres.2010.11.025","article-title":"Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey","volume":"91","author":"Mohamud","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ypmed.2013.01.005_bb0070","first-page":"11","article-title":"The relation of insulin resistance syndromes to risk of cardiovascular disease","volume":"4","author":"Nesto","year":"2003","journal-title":"Rev. Cardiovasc. Med."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743513000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743513000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T08:00:29Z","timestamp":1539936029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743513000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":14,"alternative-id":["S0091743513000182"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2013.01.005","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2013.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}